- Home
- OM vs BTMD Comparison
OM vs BTMD Comparison
Compare OM & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OM | BTMD |
|---|---|---|
| Founded | 2003 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 85.0M | 80.4M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | OM | BTMD |
|---|---|---|
| Price | $3.40 | $2.68 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $16.00 | $6.00 |
| AVG Volume (30 Days) | ★ 496.7K | 116.6K |
| Earning Date | 11-10-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 270.48 |
| EPS | N/A | ★ 0.78 |
| Revenue | $120,069,000.00 | ★ $195,645,000.00 |
| Revenue This Year | $5.77 | N/A |
| Revenue Next Year | $9.12 | $2.80 |
| P/E Ratio | ★ N/A | $3.44 |
| Revenue Growth | ★ 4.65 | 1.34 |
| 52 Week Low | $3.10 | $2.32 |
| 52 Week High | $25.35 | $6.36 |
Technical Indicators
Market Signals| Indicator | OM | BTMD |
|---|---|---|
| Relative Strength Index (RSI) | 23.48 | 49.71 |
| Support Level | $3.66 | $2.56 |
| Resistance Level | $3.83 | $2.80 |
| Average True Range (ATR) | 0.27 | 0.14 |
| MACD | 0.19 | 0.01 |
| Stochastic Oscillator | 18.36 | 37.14 |
Price Performance
Historical ComparisonAbout OM Outset Medical Inc.
Outset Medical Inc is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.
About BTMD Biote Corp.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company derives revenue from United States and also has its presence in other countries.